NDC 67296-2198 – Emtricitabine and tenofovir disoproxil fumarate

Emtricitabine 200 mg/1; Tenofovir Disoproxil Fumarate 300 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC67296-2198

Product details

Brand name
Emtricitabine and tenofovir disoproxil fumarate
Generic name
Emtricitabine and tenofovir disoproxil fumarate
Labeler
Redpharm Drug
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
ANDA · ANDA201806
Marketed since
October 7, 2021
Listing expires
December 31, 2026
Pharmacologic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Emtricitabine and tenofovir disoproxil fumarate →

Package NDC codes (2)

Package NDCDescriptionSince
67296-2198-33 TABLET, FILM COATED in 1 BOTTLE (67296-2198-3)Oct 7, 2021
67296-2198-55 TABLET, FILM COATED in 1 BOTTLE (67296-2198-5)Oct 7, 2021

Other Emtricitabine and tenofovir disoproxil fumarate products